Yukihiko Adachi

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.

E. Gabazza, Tetsu Kobayashi, O. Taguchi, 2001, American journal of respiratory and critical care medicine.

Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise.

M. Yoshida, E. Gabazza, Tetsu Kobayashi, 1997, The European respiratory journal.

Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus.

H. Shiku, H. Wada, Y. Adachi, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Thrombin stimulates the expression of PDGF in lung epithelial cells.

Tatsuya Hayashi, E. Gabazza, M. Ido, 2000, American journal of physiology. Lung cellular and molecular physiology.

Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients

N. Bruno, E. Gabazza, O. Taguchi, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Protein C anticoagulant system in patients with interstitial lung disease.

J. Nishioka, E. Gabazza, H. Wada, 1998, American journal of respiratory and critical care medicine.

Protective role of protein C inhibitor in monocrotaline‐induced pulmonary hypertension

N. Bruno, Tatsuya Hayashi, E. Gabazza, 2006, Journal of thrombosis and haemostasis : JTH.

Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients.

E. Gabazza, Koji Suzuki, Y. Adachi, 2002, The Journal of clinical endocrinology and metabolism.